Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Assets Average (2019 - 2025)

Historic Assets Average for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $171.0 million.

  • Korro Bio's Assets Average fell 3065.23% to $171.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.0 million, marking a year-over-year decrease of 3065.23%. This contributed to the annual value of $224.0 million for FY2024, which is 5162.34% up from last year.
  • Latest data reveals that Korro Bio reported Assets Average of $171.0 million as of Q3 2025, which was down 3065.23% from $191.3 million recorded in Q2 2025.
  • Korro Bio's Assets Average's 5-year high stood at $253.1 million during Q1 2021, with a 5-year trough of $62.9 million in Q3 2023.
  • Its 5-year average for Assets Average is $175.6 million, with a median of $191.3 million in 2025.
  • Its Assets Average has fluctuated over the past 5 years, first crashed by 5598.71% in 2023, then surged by 29220.8% in 2024.
  • Over the past 5 years, Korro Bio's Assets Average (Quarter) stood at $193.8 million in 2021, then tumbled by 45.88% to $104.9 million in 2022, then increased by 27.77% to $134.0 million in 2023, then skyrocketed by 75.28% to $234.9 million in 2024, then fell by 27.21% to $171.0 million in 2025.
  • Its last three reported values are $171.0 million in Q3 2025, $191.3 million for Q2 2025, and $214.2 million during Q1 2025.